EMPhasis on Mutant Microglia: Dysregulation of Brain Sentinels Induces Neurodegeneration

Bettina Schreiner1, Melanie Greter2

  • 1Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

Cell Stem Cell
|November 4, 2017
PubMed

Insights

Targeted mutation of the BRAF gene in early erythro-myeloid precursors (EMPs) triggers neurodegeneration. This process is driven by activated microglia, highlighting a novel link between genetic mutations and neurodegenerative pathology.

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Reactive microglia are increasingly recognized as key players in the progression of neurodegenerative diseases.
  • Understanding the origins and triggers of microglial activation is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the causal link between specific genetic mutations in early hematopoietic precursors and the development of late-onset neurodegeneration.
  • To elucidate the role of activated microglia in histiocytosis-associated neurodegenerative conditions.

Main Methods:

  • The study involved targeted mutation of the BRAF gene in early erythro-myeloid precursors (EMPs) in a model system.
  • Histopathological analysis and neurodegeneration assessment were performed to evaluate the consequences of the genetic manipulation.

Main Results:

  • Targeted BRAF mutation in EMPs led to the development of histiocytosis.
  • This condition was associated with late-onset neurodegeneration.
  • Activated microglia were identified as the driving force behind the observed neurodegeneration.

Conclusions:

  • Genetic alterations in early myeloid precursors, specifically BRAF mutations, can initiate a cascade leading to neurodegeneration.
  • Activated microglia play a critical role in mediating neurodegenerative pathology in this context.
  • This research provides a novel mechanistic insight into the pathogenesis of certain neurodegenerative disorders.